Motif Neurotech For decades, doctors have tried to treat depression with electricity. Now, a Houston startup wants to ...

MintNeuro and Motif Neurotech today announced plans to accelerate the clinical availability of therapeutic brain-computer ...

MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

MintNeuro and Motif Neurotech have announced a strategic partnership aimed at advancing miniature brain-computer interface ...

A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest ...

A device the size of a blueberry is hypothesized to give people with treatment-resistant depression another option — and the FDA is giving its Houston maker a chance to test it.

Brain implant gets FDA clearance for first wireless depression treatment trial, offering battery-free stimulation in ...

FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...

Motif Neurotech announced today that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation ...

Motif’s study primarily aims to validate the safety of its XCS system over a 12-month period following implantation.